List of Contents

Ambulatory EHR Market Size, Share, and Trends 2024 to 2034

Ambulatory EHR Market (By Deployment Mode: Cloud/Web-based, On-premise; By Type: By Type, Modular; By Practice Size: Large Practices, Small-to-medium-sized Practices, Solo Practices; By Application: Practice Management, Patient Portals, Computerized Physician Order Entry, Clinical Decision Support, Population Health Management, Referral Management, Other Applications; By End User) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032

  • Last Updated : August 2023
  • Report Code : 2311
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Ambulatory EHR Market 

5.1. COVID-19 Landscape: Ambulatory EHR Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Ambulatory EHR Market, By Deployment Mode

8.1. Ambulatory EHR Market, by Deployment Mode, 2023-2032

8.1.1. Cloud/Web-based

8.1.1.1. Market Revenue and Forecast (2021-2032)

8.1.2. On-premise

8.1.2.1. Market Revenue and Forecast (2021-2032)

Chapter 9. Global Ambulatory EHR Market, By Type

9.1. Ambulatory EHR Market, by Type, 2023-2032

9.1.1. All-in-one

9.1.1.1. Market Revenue and Forecast (2021-2032)

9.1.2. Modular

9.1.2.1. Market Revenue and Forecast (2021-2032)

Chapter 10. Global Ambulatory EHR Market, By Practice Size 

10.1. Ambulatory EHR Market, by Practice Size, 2023-2032

10.1.1. Large Practices

10.1.1.1. Market Revenue and Forecast (2021-2032)

10.1.2. Small-to-medium-sized Practices

10.1.2.1. Market Revenue and Forecast (2021-2032)

10.1.3. Solo Practices

10.1.3.1. Market Revenue and Forecast (2021-2032)

Chapter 11. Global Ambulatory EHR Market, By Application

11.1. Ambulatory EHR Market, by Application, 2023-2032

11.1.1. Practice Management

11.1.1.1. Market Revenue and Forecast (2021-2032)

11.1.2. Patient Portals

11.1.2.1. Market Revenue and Forecast (2021-2032)

11.1.3. Computerized Physician Order Entry (CPOE)

11.1.3.1. Market Revenue and Forecast (2021-2032)

11.1.4. Clinical Decision Support (CDS)

11.1.4.1. Market Revenue and Forecast (2021-2032)

11.1.5. Population Health Management

11.1.5.1. Market Revenue and Forecast (2021-2032)

11.1.6. Referral Management

11.1.6.1. Market Revenue and Forecast (2021-2032)

11.1.7. Others

11.1.7.1. Market Revenue and Forecast (2021-2032)

Chapter 12. Global Ambulatory EHR Market, By End User

12.1. Ambulatory EHR Market, by End User, 2023-2032

12.1.1. Hospital-owned Ambulatory Centres

12.1.1.1. Market Revenue and Forecast (2021-2032)

12.1.2. Independent Ambulatory Centres

12.1.2.1. Market Revenue and Forecast (2021-2032)

Chapter 13. Global Ambulatory EHR Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Deployment Mode (2021-2032)

13.1.2. Market Revenue and Forecast, by Type (2021-2032)

13.1.3. Market Revenue and Forecast, by Practice Size (2021-2032)

13.1.4. Market Revenue and Forecast, by Application (2021-2032)

13.1.5. Market Revenue and Forecast, by End User (2021-2032)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Deployment Mode (2021-2032)

13.1.6.2. Market Revenue and Forecast, by Type (2021-2032)

13.1.6.3. Market Revenue and Forecast, by Practice Size (2021-2032)

13.1.6.4. Market Revenue and Forecast, by Application (2021-2032)

13.1.6.5. Market Revenue and Forecast, by End User (2021-2032) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Deployment Mode (2021-2032)

13.1.7.2. Market Revenue and Forecast, by Type (2021-2032)

13.1.7.3. Market Revenue and Forecast, by Practice Size (2021-2032)

13.1.7.4. Market Revenue and Forecast, by Application (2021-2032)

13.1.7.5. Market Revenue and Forecast, by End User (2021-2032)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Deployment Mode (2021-2032)

13.2.2. Market Revenue and Forecast, by Type (2021-2032)

13.2.3. Market Revenue and Forecast, by Practice Size (2021-2032)

13.2.4. Market Revenue and Forecast, by Application (2021-2032) 

13.2.5. Market Revenue and Forecast, by End User (2021-2032) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Deployment Mode (2021-2032)

13.2.6.2. Market Revenue and Forecast, by Type (2021-2032)

13.2.6.3. Market Revenue and Forecast, by Practice Size (2021-2032)

13.2.7. Market Revenue and Forecast, by Application (2021-2032) 

13.2.8. Market Revenue and Forecast, by End User (2021-2032) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Deployment Mode (2021-2032)

13.2.9.2. Market Revenue and Forecast, by Type (2021-2032)

13.2.9.3. Market Revenue and Forecast, by Practice Size (2021-2032)

13.2.10. Market Revenue and Forecast, by Application (2021-2032)

13.2.11. Market Revenue and Forecast, by End User (2021-2032)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Deployment Mode (2021-2032)

13.2.12.2. Market Revenue and Forecast, by Type (2021-2032)

13.2.12.3. Market Revenue and Forecast, by Practice Size (2021-2032)

13.2.12.4. Market Revenue and Forecast, by Application (2021-2032)

13.2.13. Market Revenue and Forecast, by End User (2021-2032)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Deployment Mode (2021-2032)

13.2.14.2. Market Revenue and Forecast, by Type (2021-2032)

13.2.14.3. Market Revenue and Forecast, by Practice Size (2021-2032)

13.2.14.4. Market Revenue and Forecast, by Application (2021-2032)

13.2.15. Market Revenue and Forecast, by End User (2021-2032)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Deployment Mode (2021-2032)

13.3.2. Market Revenue and Forecast, by Type (2021-2032)

13.3.3. Market Revenue and Forecast, by Practice Size (2021-2032)

13.3.4. Market Revenue and Forecast, by Application (2021-2032)

13.3.5. Market Revenue and Forecast, by End User (2021-2032)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Deployment Mode (2021-2032)

13.3.6.2. Market Revenue and Forecast, by Type (2021-2032)

13.3.6.3. Market Revenue and Forecast, by Practice Size (2021-2032)

13.3.6.4. Market Revenue and Forecast, by Application (2021-2032)

13.3.7. Market Revenue and Forecast, by End User (2021-2032)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Deployment Mode (2021-2032)

13.3.8.2. Market Revenue and Forecast, by Type (2021-2032)

13.3.8.3. Market Revenue and Forecast, by Practice Size (2021-2032)

13.3.8.4. Market Revenue and Forecast, by Application (2021-2032)

13.3.9. Market Revenue and Forecast, by End User (2021-2032)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Deployment Mode (2021-2032)

13.3.10.2. Market Revenue and Forecast, by Type (2021-2032)

13.3.10.3. Market Revenue and Forecast, by Practice Size (2021-2032)

13.3.10.4. Market Revenue and Forecast, by Application (2021-2032)

13.3.10.5. Market Revenue and Forecast, by End User (2021-2032)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Deployment Mode (2021-2032)

13.3.11.2. Market Revenue and Forecast, by Type (2021-2032)

13.3.11.3. Market Revenue and Forecast, by Practice Size (2021-2032)

13.3.11.4. Market Revenue and Forecast, by Application (2021-2032)

13.3.11.5. Market Revenue and Forecast, by End User (2021-2032)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Deployment Mode (2021-2032)

13.4.2. Market Revenue and Forecast, by Type (2021-2032)

13.4.3. Market Revenue and Forecast, by Practice Size (2021-2032)

13.4.4. Market Revenue and Forecast, by Application (2021-2032)

13.4.5. Market Revenue and Forecast, by End User (2021-2032)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Deployment Mode (2021-2032)

13.4.6.2. Market Revenue and Forecast, by Type (2021-2032)

13.4.6.3. Market Revenue and Forecast, by Practice Size (2021-2032)

13.4.6.4. Market Revenue and Forecast, by Application (2021-2032)

13.4.7. Market Revenue and Forecast, by End User (2021-2032)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Deployment Mode (2021-2032)

13.4.8.2. Market Revenue and Forecast, by Type (2021-2032)

13.4.8.3. Market Revenue and Forecast, by Practice Size (2021-2032)

13.4.8.4. Market Revenue and Forecast, by Application (2021-2032)

13.4.9. Market Revenue and Forecast, by End User (2021-2032)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Deployment Mode (2021-2032)

13.4.10.2. Market Revenue and Forecast, by Type (2021-2032)

13.4.10.3. Market Revenue and Forecast, by Practice Size (2021-2032)

13.4.10.4. Market Revenue and Forecast, by Application (2021-2032)

13.4.10.5. Market Revenue and Forecast, by End User (2021-2032)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Deployment Mode (2021-2032)

13.4.11.2. Market Revenue and Forecast, by Type (2021-2032)

13.4.11.3. Market Revenue and Forecast, by Practice Size (2021-2032)

13.4.11.4. Market Revenue and Forecast, by Application (2021-2032)

13.4.11.5. Market Revenue and Forecast, by End User (2021-2032)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Deployment Mode (2021-2032)

13.5.2. Market Revenue and Forecast, by Type (2021-2032)

13.5.3. Market Revenue and Forecast, by Practice Size (2021-2032)

13.5.4. Market Revenue and Forecast, by Application (2021-2032)

13.5.5. Market Revenue and Forecast, by End User (2021-2032)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Deployment Mode (2021-2032)

13.5.6.2. Market Revenue and Forecast, by Type (2021-2032)

13.5.6.3. Market Revenue and Forecast, by Practice Size (2021-2032)

13.5.6.4. Market Revenue and Forecast, by Application (2021-2032)

13.5.7. Market Revenue and Forecast, by End User (2021-2032)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Deployment Mode (2021-2032)

13.5.8.2. Market Revenue and Forecast, by Type (2021-2032)

13.5.8.3. Market Revenue and Forecast, by Practice Size (2021-2032)

13.5.8.4. Market Revenue and Forecast, by Application (2021-2032)

13.5.8.5. Market Revenue and Forecast, by End User (2021-2032)

Chapter 14. Company Profiles

14.1. AdvancedMD, Inc. (U.S.)

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Allscripts Healthcare Solutions, Inc. (US)

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Amazing Charts, LLC (The U.S)

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Athenahealth (The U.S)

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. CareCloud, Inc. (The U.S)

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Cerner Corporation (US)

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Computer Programs and Systems, Inc. (US)

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. CureMD Healthcare (The U.S)

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. DrChrono (The U.S)

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. eClinicalWorks (The U.S)

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client